This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2019 Jul 16;74(2):216-218.

doi: 10.1016/j.jacc.2019.05.050.

Paclitaxel-Eluting Devices for Femoropopliteal Disease: Drastic Advance in Therapy or a Danger to Our Patients?

Affiliations

PMID: 31296294
DOI: 10.1016/j.jacc.2019.05.050

Free article

Editorial

Paclitaxel-Eluting Devices for Femoropopliteal Disease: Drastic Advance in Therapy or a Danger to Our Patients?

John R Laird. J Am Coll Cardiol. 2019.

Free article

. 2019 Jul 16;74(2):216-218.

doi: 10.1016/j.jacc.2019.05.050.

Author

Affiliation

¹ Adventist Heart and Vascular Institute, St. Helena, California. Electronic address: lairdjr@ah.org.

PMID: 31296294
DOI: 10.1016/j.jacc.2019.05.050

No abstract available

Keywords: DCB; DES; restenosis.

PubMed Disclaimer

Comment on

Drug-Eluting Balloon Versus Drug-Eluting Stent for Complex Femoropopliteal Arterial Lesions: The DRASTICO Study.
Liistro F, Angioli P, Porto I, Ducci K, Falsini G, Ventoruzzo G, Ricci L, Scatena A, Grotti S, Bolognese L. Liistro F, et al. J Am Coll Cardiol. 2019 Jul 16;74(2):205-215. doi: 10.1016/j.jacc.2019.04.057. J Am Coll Cardiol. 2019. PMID: 31296293 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science